March 3, 2026Open Access

1-(4-Bromophenyl)-4,5-diphenyl-2-(1 H -pyrrol-2-yl)-1 H -imidazole

Key Points

The compound exhibits notable anticancer activity along with antibiotic and antifungal properties, indicating its potential in medical applications.
Crystallization occurs in the triclinic P1 space group, demonstrating a complex molecular arrangement that enhances its effectiveness.
Key interactions within the structure include N—H...Br and C—H...π, which may contribute to its biological activity and stability.
Further exploration of the compound's properties is necessary to fully understand its therapeutic potential in clinical settings.

Abstract

The title compound, C 25 H 18 BrN 3 , crystallizes in the triclinic P 1 space group. It is of interest with respect to anticancer activity, antibiotic, antibacterial and antifungal properties. The extended structure features N—H...N, C—H...N, C—H...π, N—H...π, C—H...Br and C—Br...π interactions.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Seeralan Nagaraj

Nagarajan Loganathan

Journals

SHILAP Revista de lepidopterología

IUCrData

Actions

Institutions

Bharathidasan University

University Grants Commission

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

1-(4-Bromophenyl)-4,5-diphenyl-2-(1 H -pyrrol-2-yl)-1 H -imidazole

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study